Michel Fontés

Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease

E. Passage, Jean Chrétien Norreel, Pauline Noack-Fraissignes et al. · Nature Medicine · 2004 · 340 citations

Charcot-marie-tooth Disease, Medicine, Physiology +7

Effect of ascorbic acid in patients with Charcot–Marie–Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial

Joëlle Micallef, Shahram Attarian, O. Dubourg et al. · The Lancet Neurology · 2009 · 131 citations

Ascorbic Acid, Dental Disease, Placebo-controlled Trial +2

Prominent and Persistent Extraneural Infection in Human PrP Transgenic Mice Infected with Variant CJD

Vincent Béringue, Annick Le Dur, Philippe Tixador et al. · PLoS ONE · 2008 · 115 citations · Full text

The human EZH2 gene: genomic organisation and revised mapping in 7q35 within the critical region for malignant myeloid disorders

Carlos Cardoso, C. Mignon, Gilles Hetet et al. · European Journal of Human Genetics · 2000 · 110 citations · Full text

Hematological Malignancy, Chromatin, Cancer Research +12

Ascorbic acid inhibits PMP22 expression by reducing cAMP levels

Ferdinand Kaya, Sophie Belin, Patrice Bourgeois et al. · Neuromuscular Disorders · 2007 · 80 citations

Redox Signaling, Biochemistry, Natural Sciences +10